Zoom Meeting:
https://mc-meet.zoom.us/j/96023130705?pwd=TTVCN2xGVGp1T3l2d0h3bzBrbmdidz09

Meeting ID: 960 2313 0705
Passcode: 937081

NCC Service
Stephanie Steel, M.D.
Sara Hocker, M.D.
"Super Refractory Status Epilepticus; New Onset Refractory Status Epilepticus; Cryptogenic Status Epilepticus; Medically Refractory Epilepsy; Management Considerations"

Learning objectives
Upon conclusion of this activity, participants will be able to:

• Recognize new-onset refractory status epilepticus (NORSE) etiology, clinical features, and outcome
• Review long-term epilepsy follow-up and treatment including immune therapies
• Identify best management of a current patient with resolved cryptogenic NORSE and ongoing seizures

The presenters (nor spouses/partners) do not have a relevant financial relationship to disclose. They do intend to discuss off-label/investigative uses of the following commercial products/devices: tocilizumab, rituximab, anakinra.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.